| 1 | CCND2, GDDMP, MAX
|
| A recurrent de novo MAX p.Arg60Gln variant causes a syndromic overgrowth disorder through differential expression of c-Myc target genes
|
| Harris EL, Roy V, Montagne M, Rose AMS, Livesey H, Reijnders MRF, Hobson E, Sansbury FH, Willemsen MH, Pfundt R, Warren D, Long V, Carr IM, Brunner HG, Sheridan EG, Firth HV, Lavigne P, Poulter JA.
|
| Am J Hum Genet. Jan 4;111(1):119-132. doi: 10.1016/j.ajhg.2023.11.010. Epub 2023 Dec 22 2024
|
| 2 | MAX
|
| Validation of Myc-Associated Protein X (MAX) regulation in growth hormone secreting and nonfunctional pituitary adenoma.
|
| Tucker DW, Pangal DJ, Du R, Gogia AS, Tafreshi A, Ruzevick J, Hurth KT, Triche T Jr, Micko A, Carpten JD, Shiroishi MS, Carmichael JD, Rhie SK, Zada G.
|
| PLoS One Apr 27;18(4):e0284949. doi: 10.1371/journal.pone.0284949. 2023
|
| 3 | MAX, OSR2
|
| MAX deficiency impairs human endometrial decidualization through down-regulating OSR2 in women with recurrent spontaneous abortion.
|
| Ma W, Cao M, Bi S, Du L, Chen J, Wang H, Jiang Y, Wu Y, Liao Y, Kong S, Liu J.
|
| Cell Tissue Res. May;388(2):453-469. doi: 10.1007/s00441-022-03579-z. Epub 2022 Feb 11. 2022
|
| 4 | ARNTL, MAX
|
| MYC-Associated Factor MAX is a Regulator of the Circadian Clock
|
| Blaževitš O, Bolshette N, Vecchio D, Guijarro A, Croci O, Campaner S, Grimaldi B
|
| Int J Mol Sci. Mar 26;21(7):2294. doi: 10.3390/ijms21072294. 2020
|
| 5 | MAX
|
| Does MAX open up a new avenue for meiotic research? 2017 PMID:
|
| Suzuki A, Hirasaki M, Okuda A.
|
| Dev Growth Differ. Feb;59(2):61-69. doi: 10.1111/dgd.12344. Epub 2017 Feb 20. 2017
|
| 6 | MAX
|
| Hypoxia reduces MAX expression in endothelial cells by unproductive splicing.
|
| Kemmerer K, Weigand JE.
|
| FEBS Lett. Dec 20;588(24):4784-90. doi: 10.1016/j.febslet.2014.11.011. Epub 2014 Nov 15 2014
|
| 7 | MAX
|
| MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma
|
| Burnichon N, Cascón A, Schiavi F, Morales NP, Comino-Méndez I, Abermil N, Inglada-Pérez L, de Cubas AA, Amar L, Barontini M, de Quirós SB, Bertherat J, Bignon YJ, Blok MJ, Bobisse S, Borrego S, Castellano M, Chanson P, Chiara MD, Corssmit EP, Giacchè M, de Krijger RR, Ercolino T, Girerd X, Gómez-García EB, Gómez-Graña A, Guilhem I, Hes FJ, Honrado E, Korpershoek E, Lenders JW, Letón R, Mensenkamp AR, Merlo A, Mori L, Murat A, Pierre P, Plouin PF, Prodanov T, Quesada-Charneco M, Qin N, Rapizzi E, Raymond V, Reisch N, Roncador G, Ruiz-Ferrer M, Schillo F, Stegmann AP, Suarez C, Taschin E, Timmers HJ, Tops CM, Urioste M, Beuschlein F, Pacak K, Mannelli M, Dahia PL, Opocher G, Eisenhofer G, Gimenez-Roqueplo AP, Robledo M.
|
| Clin Cancer Res. May 15;18(10):2828-37. doi: 10.1158/1078-0432.CCR-12-0160. Epub 2012 Mar 27 2012
|
| 8 | MAX
|
| Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma.
|
| Comino-Méndez I, Gracia-Aznárez FJ, Schiavi F, Landa I, Leandro-García LJ, Letón R, Honrado E, Ramos-Medina R, Caronia D, Pita G, Gómez-Graña A, de Cubas AA, Inglada-Pérez L, Maliszewska A, Taschin E, Bobisse S, Pica G, Loli P, Hernández-Lavado R, Díaz JA, Gómez-Morales M, González-Neira A, Roncador G, Rodríguez-Antona C, Benítez J, Mannelli M, Opocher G, Robledo M, Cascón A.
|
| Nat Genet 43(7):663-7. doi: 10.1038/ng.861.
2011
|
| 9 | MAX, MYC
|
| Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
|
| Mao B, Zhao G, Lv X, Chen HZ, Xue Z, Yang B, Liu DP, Liang CC.
|
| Int J Biochem Cell Biol 43(11):1573-81. doi: 10.1016/j.biocel.2011.07.006. Epub 2011 Jul 22.
2011
|
| 10 | MAX, MYC, ZBTB17
|
| The interaction between Myc and Miz1 is required to antagonize TGFbeta-dependent autocrine signaling during lymphoma formation and maintenance.
|
| van Riggelen J, Müller J, Otto T, Beuger V, Yetil A, Choi PS, Kosan C, Möröy T, Felsher DW, Eilers M.
|
| Genes Dev 24(12):1281-94.PMID: 20551174 2010
|
| 11 | CEBPD, MAX, MYC, ZBTB17
|
| Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression.
|
| Si J, Yu X, Zhang Y, DeWille JW.
|
| Mol Cancer 9:92.
2010
|
| 12 | MAX, MNT, MYC
|
| Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.
|
| Yang H, Li TW, Ko KS, Xia M, Lu SC.
|
| Hepatology 49(3):860-70.
2009
|
| 13 | MAX
|
| Max is acetylated by p300 at several nuclear localization residues.
|
| Faiola F, Wu YT, Pan S, Zhang K, Farina A, Martinez E.
|
| Biochem J 403(3):397-407.
2007
|
| 14 | MAX
|
| Thermodynamics of protein-protein interactions of cMyc, Max, and Mad: effect of polyions on protein dimerization.
|
| Banerjee A, Hu J, Goss DJ.
|
| Biochemistry 45(7):2333-8. 2006
|
| 15 | MAX
|
| Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells.
|
| Smith AG, Popov N, Imreh M, Axelson H, Henriksson M.
|
| J Cell Biochem 92(6):1282-95. 2004
|
| 16 | CASP5, MAX
|
| Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1.
|
| Krippner-Heidenreich A, Talanian RV, Sekul R, Kraft R, Thole H, Ottleben H, Luscher B.
|
| Biochem J 358(Pt 3):705-15. 2001
|
| 17 | MAX
|
| Expression, regulaion, and chromosomal localization of the Max gene.
|
| Wagner AJ, et al.
|
| Proc Natl Acad Sci U S A 89 : 3111-3115. 1992
|
| 18 | MAX
|
| Mapping of MAX to human chromosome 14 and mouse chromosome 12 by in situ hybridization.
|
| Gilladoga AD, et al.
|
| Oncogene 7 : 1249-1251. 1992
|
| 19 | MAX, MYC
|
| Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation.
|
| Makela TP, Koskinen PJ, Vastrik I, Alitalo K.
|
| Science 256(5055):373-7. 1992
|